21 Hrs
Source:
The Washington Post
_1777370220974_847775619.png&w=64&q=75){kind=small}
FDA studies for many products incomplete
The FDA allows companies to conduct postmarket studies to accelerate the approval process for drugs and devices. However, records indicate that many of these studies are frequently delayed or overdue.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)